Twist Bioscience Corp at JPMorgan Healthcare Conference Transcript
Hi, everybody. My name is Casey Woodring from the Life Science Tools and Diagnostics team here at JPM. Pleased to introduce our next company, Twist Bioscience, joined here by the management team. We will be doing a brief presentation and then a Q&A afterwards. And so now without further ado, CEO, Emily Leproust.
Thank you very much for the invitation and the introduction. It's a great pleasure to be here. I'll start by saying that today, I'll be making some forward-looking statements.
And so at Twist, as you know, we have a platform to write DNA, and we have enabled a large number of applications shown on the screen. And beyond DNA, once you've made the DNA, you're halfway there to get to the RNA and then you're almost there to make to the protein. And so we are expanding our product line into RNA and proteins.
And really, there's 3 things to remember for today's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |